340 related articles for article (PubMed ID: 28430865)
1. Unmet needs in the first-line treatment of follicular lymphoma.
Casulo C; Nastoupil L; Fowler NH; Friedberg JW; Flowers CR
Ann Oncol; 2017 Sep; 28(9):2094-2106. PubMed ID: 28430865
[TBL] [Abstract][Full Text] [Related]
2. Thirty-Month Complete Response as a Surrogate End Point in First-Line Follicular Lymphoma Therapy: An Individual Patient-Level Analysis of Multiple Randomized Trials.
Shi Q; Flowers CR; Hiddemann W; Marcus R; Herold M; Hagenbeek A; Kimby E; Hochster H; Vitolo U; Peterson BA; Gyan E; Ghielmini M; Nielsen T; De Bedout S; Fu T; Valente N; Fowler NH; Hoster E; Ladetto M; Morschhauser F; Zucca E; Salles G; Sargent DJ
J Clin Oncol; 2017 Feb; 35(5):552-560. PubMed ID: 28029309
[TBL] [Abstract][Full Text] [Related]
3. Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs.
Matasar MJ; Luminari S; Barr PM; Barta SK; Danilov AV; Hill BT; Phillips TJ; Jerkeman M; Magagnoli M; Nastoupil LJ; Persky DO; Okosun J
Oncologist; 2019 Nov; 24(11):e1236-e1250. PubMed ID: 31346132
[TBL] [Abstract][Full Text] [Related]
4. 90Yttrium-ibritumomab tiuxetan consolidation of first remission in advanced-stage follicular non-Hodgkin lymphoma: updated results after a median follow-up of 7.3 years from the International, Randomized, Phase III First-LineIndolent trial.
Morschhauser F; Radford J; Van Hoof A; Botto B; Rohatiner AZ; Salles G; Soubeyran P; Tilly H; Bischof-Delaloye A; van Putten WL; Kylstra JW; Hagenbeek A
J Clin Oncol; 2013 Jun; 31(16):1977-83. PubMed ID: 23547079
[TBL] [Abstract][Full Text] [Related]
5. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project.
Federico M; Bellei M; Marcheselli L; Luminari S; Lopez-Guillermo A; Vitolo U; Pro B; Pileri S; Pulsoni A; Soubeyran P; Cortelazzo S; Martinelli G; Martelli M; Rigacci L; Arcaini L; Di Raimondo F; Merli F; Sabattini E; McLaughlin P; Solal-Céligny P
J Clin Oncol; 2009 Sep; 27(27):4555-62. PubMed ID: 19652063
[TBL] [Abstract][Full Text] [Related]
6. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.
Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N
Cochrane Database Syst Rev; 2012 Jan; 1():CD007678. PubMed ID: 22258971
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of mid- and post-treatment [(18)F]fluorodeoxyglucose (FDG) positron emission tomography (PET) in indolent follicular lymphoma.
Lu Z; Lin M; Downe P; Chong S; Ling S
Ann Nucl Med; 2014 Oct; 28(8):805-11. PubMed ID: 25008291
[TBL] [Abstract][Full Text] [Related]
8. End of induction positron emission tomography complete response (PET-CR) as a surrogate for progression-free survival in previously untreated follicular lymphoma.
Dixon JG; Dimier N; Nielsen T; Zheng J; Marcus R; Morschhauser F; Evens AM; Federico M; Blum KA; Shi Q
Br J Haematol; 2022 Jul; 198(2):333-337. PubMed ID: 35491747
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR.
Sureda A; Zhang MJ; Dreger P; Carreras J; Fenske T; Finel H; Schouten H; Montoto S; Robinson S; Smith SM; Boumedil A; Hamadani M; Pasquini MC
Cancer; 2018 Apr; 124(8):1733-1742. PubMed ID: 29424927
[TBL] [Abstract][Full Text] [Related]
10. FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUV
Annunziata S; Cuccaro A; Tisi MC; Hohaus S; Rufini V
Ann Nucl Med; 2018 Jun; 32(5):372-377. PubMed ID: 29464479
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in follicular lymphoma: new tools to personalize risk.
Casulo C
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):269-276. PubMed ID: 27913491
[TBL] [Abstract][Full Text] [Related]
12. [Follicular lymphoma. High-dose immunochemotherapy with autologous blood stem cell transplantation: Results of the first prospective study in Russia].
Nesterova ES; Kravchenko SK; Mangasarova YK; Baryakh EA; Misyurina AE; Vorobyev VI; Plastinina LV; Chernova NG; Kovrigina AM; Obukhova TN; Klyasova GA; Shevelev AA; Kostina IE; Gemdzhian EG; Gaponova TV; Vorobyev AI
Ter Arkh; 2016; 88(7):62-71. PubMed ID: 27459617
[TBL] [Abstract][Full Text] [Related]
13. Front-line management of non-Hodgkin lymphoma in Australia. Part 1: follicular lymphoma.
Trotman J; Cheah CY; Marlton P; Opat S
Intern Med J; 2019 Apr; 49(4):422-433. PubMed ID: 30230156
[TBL] [Abstract][Full Text] [Related]
14. Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study†.
Casulo C; Day B; Dawson KL; Zhou X; Flowers CR; Farber CM; Hainsworth JD; Cerhan JR; Link BK; Zelenetz AD; Friedberg JW
Ann Oncol; 2015 Nov; 26(11):2311-7. PubMed ID: 26362568
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era.
Belotti A; Doni E; Bolis S; Rossini F; Casaroli I; Pezzatti S; Pogliani EM; Pioltelli PE
Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):208-13. PubMed ID: 25468321
[TBL] [Abstract][Full Text] [Related]
16. Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis.
Sarkozy C; Baseggio L; Feugier P; Callet-Bauchu E; Karlin L; Seymour JF; Lebras L; Michallet AS; Offner F; Dumas O; Traverse-Glehen A; Ffrench M; Lopez-Guillermo A; Berger F; Coiffier B; Felman P; Salles G
Br J Haematol; 2014 Mar; 164(5):659-67. PubMed ID: 24274024
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in follicular lymphoma.
Relander T; Johnson NA; Farinha P; Connors JM; Sehn LH; Gascoyne RD
J Clin Oncol; 2010 Jun; 28(17):2902-13. PubMed ID: 20385990
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Correlation Between Early and Late Efficacy Endpoints to Identify Potential Surrogacy Relationships in Non-Hodgkin Lymphoma: a Literature-Based Meta-analysis of 108 Phase II and Phase III Studies.
Zhu R; Lu D; Chu YW; Chai A; Green M; Zhang N; Jin JY
AAPS J; 2017 May; 19(3):669-681. PubMed ID: 28224402
[TBL] [Abstract][Full Text] [Related]
19. [Clinical Features, Treatment and Prognostic Factors of 94 Patients with Follicular Lymphoma].
DU XY; Hu K; Zhao W; Yang P; Wan W; Jing HM; Ke XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):756-764. PubMed ID: 29950216
[TBL] [Abstract][Full Text] [Related]
20. Current and future therapeutic approaches for the treatment of follicular lymphoma.
Pulsoni A; Cappelli LV; Ballotta L; Canichella M; Serrao A; Annechini G; D'Elia GM; Foà R
Expert Rev Anticancer Ther; 2018 Sep; 18(9):931-941. PubMed ID: 29972084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
